Sign In
Buy TLRY
$5.11
-0.270 (-5.02%)
At Close: Jun 03, 2026
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
11:55am, Tuesday, 06'th Jan 2026
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
Best Canadian Cannabis Stocks to Watch Entering 2026
10:00am, Tuesday, 06'th Jan 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr
Tilray stock forms a risky pattern: Jan. 8 will be key
07:30am, Tuesday, 06'th Jan 2026
Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump's cannabis reclassification efforts and its implications. It surged from $3.59 in June to a high
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages
07:00am, Tuesday, 06'th Jan 2026
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellnes
Top Stocks With Earnings This Week: Tilray, Applied Digital and More
07:10pm, Monday, 05'th Jan 2026
As the first full week of 2026 kicks off, the earnings calendar features a mix of early reports in the cannabis, AI infrastructure and consumer goods sectors.
Enhance Your Dry January with Mindful Sipping: Try Tilray's Mollo and XMG Cannabis Beverages
07:00am, Monday, 05'th Jan 2026
TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellnes
How Long Will the Cannabis Stock Rally Last?
03:10pm, Thursday, 01'st Jan 2026
Cannabis stocks have had significant momentum due to positive regulatory changes in the U.S. However, this momentum is likely to be relatively short-lived. These 10 Stocks Could Mint the Next Wave of
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
09:21am, Wednesday, 31'st Dec 2025
Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 investors.
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
03:28pm, Tuesday, 30'th Dec 2025
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should ha
2 Marijuana Stocks To Watch For Better Investing In 2026
01:05pm, Sunday, 28'th Dec 2025
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te
I Was Right: President Trump Will Legalize Marijuana in 2026
09:00am, Sunday, 28'th Dec 2025
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come.
3 Marijuana Stocks To Watch In 2026
01:58pm, Friday, 26'th Dec 2025
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af
Marijuana Stocks To Watch After The Holidays
11:52am, Wednesday, 24'th Dec 2025
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next
06:15am, Wednesday, 24'th Dec 2025
Tilray's shares have soared since mid-2025, driven by expectations of cannabis reclassification in the U.S. These expectations have now become a reality, and they will have an impact on pot growers in
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
04:44am, Tuesday, 23'rd Dec 2025
Trump's executive order to reclassify marijuana from Schedule I to Schedule III recognized the valid medical uses of the drug. The move could impact cannabis companies in several ways, including allow
